Sorry, there are no transactions available for this individual.
Denali Therapeutics Inc.
NAS: DNLI
/marketstate/country/us
/zigman2/quotes/200043077/composite
After Hours
--Quotes are delayed by 20 min
Mar 27, 2023, 4:08 p.m.
$
23.10
Change
-0.17 -0.73%
Volume
Volume 40,022
Quotes are delayed by 20 min
/zigman2/quotes/200043077/composite
Previous close
$ 22.90
$ 23.27
Change
+0.37 +1.62%
Day low
Day high
$22.92
$23.51
52 week low
52 week high
$20.24
$39.43
Officers and Executives
|
Dr. Ryan J. Watts President, Chief Executive Officer & Director |
|
Dr. Alexander O. Schuth Secretary, Chief Operating & Financial Officer |
|
Dr. Joe Lewcock Chief Scientific Officer |
|
Dr. Carole Ho Chief Medical Officer & Head-Development |
|
Dr. Dana Andersen CTO & Chief Manufacturing Officer |
|
Ms. Katie Peng Chief Commercial Officer |
|
Mr. Steve E. Krognes Director |
|
Dr. Laura G. Hansen Vice President-Investor Relations |
|
Ms. Cindy Dunkle Chief People Officer |
|
Dr. Chris Walsh Associate General Counsel |
|
Ms. Erica Kratz Vice President-Regulatory |
|
Dr. Vicki L. Sato Non-Executive Chairman |
|
Ms. Nancy A. Thornberry Independent Director |
|
Mr. Erik C. Harris Independent Director |
|
Dr. Marc Tessier-Lavigne Independent Director |
|
Dr. Douglas G. Cole Independent Director |
|
Mr. Jay T. Flatley Independent Director |
|
Dr. David Paul Schenkein Independent Director |
|
Mr. Peter S. Klein Independent Director |
|
Ms. Jennifer E. Cook Independent Director |
Log In
7:12 AM EDT
March 28, 2023
/marketstate/country/us
New York
Pre
/marketstate/country/uk
London
Open
/marketstate/country/jp
Tokyo
Closed
/marketstate/country/us
/marketstate/country/uk
/marketstate/country/jp
Latest News
-
/news/latest
-
German competition regulator launches antitrust investigation into Microsoft
-
Walgreens Q2 adj. EPS down 27% from a year ago to $1.16, but above the FactSet consensus $1.10
-
Why I abandoned my 529 college savings plan and switched to Series I bonds instead
-
Disney Drops Metaverse Hopes. The 'Next Storytelling Frontier' Is Out of Favor.
-
The Metaverse Suffers a Setback. That’s OK, Banking Regulation Needs to Catch Up.
-
Bowlero started at buy with $26 stock price target at Stifel Nicolaus
-
Alibaba stock up 6.6% in premarket trade on plan to form six units
-
CytomX Therapeutics stock price target cut to $2 from $4 at Mizuho
-
Unity Biotechnology stock price target cut to $6 from $12 at Mizuho
-
Marathon Petroleum downgraded to neutral from overweight at J.P. Morgan
-
BREAKING
-
McCormick & Co. Q1 adj. earnings 59c beats analyst view of 50c
-
McCormick & Co. Q1 revenue up 3% to $1.57 bln, ahead of $1.54 bln analyst estimate
-
McCormick sees FY2023 adj. EPS $2.56-$2.61, surrounds FactSet consensus $2.57
- Loading more headlines...
Kiosk
-
13203972000001320598500000/conga/kiosk/alerts.html 310238
Alerts
-
13337034000001333949700000/conga/kiosk/games.html 310284
Virtual Stock Exchange
Our free stock-market game
• Trade your virtual portfolio in real time
• Talk strategies in group discussions
• Find or create a game that suits you
• Use our learning center to improve
Copyright © 2023 MarketWatch, Inc. All rights reserved.
Subscriber Agreement & Terms of Use |
Privacy Notice |
Cookie Notice
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.